MedicalLogic

1 clinical trials · Sponsor

Record	Firm	Date
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma (NCT02146118)	MedicalLogic	2014-04-01

Every clearance here is in the API, with alerts when new ones post.